Kentucky 2022 Regular Session

Kentucky Senate Bill SB126

Introduced
1/27/22  
Refer
1/27/22  

Caption

AN ACT relating to the establishment of emergency insulin programs and declaring an emergency.

Impact

The implementation of SB126 has the potential to significantly enhance public health outcomes in Kentucky by addressing the urgent need for accessible and affordable insulin. It targets an estimated 500,000 residents diagnosed with diabetes who may struggle to afford necessary medications. Furthermore, the law establishes mechanisms for pharmacies to dispense insulin and receive compensation, which may stabilize the market and encourage more effective distribution of this critical medication.

Summary

Senate Bill 126 establishes programs to improve access to insulin for individuals in Kentucky, particularly those in urgent need of it. The bill creates two primary initiatives: the 'Urgent-Need Insulin Program' and the 'Continuing Access to Insulin Program'. The former is designed to help individuals who require insulin immediately, while the latter addresses ongoing insulin needs. Both programs will be managed by the Cabinet for Health and Family Services, aiming to ensure that eligible residents can access insulin affordably.

Sentiment

The sentiment surrounding SB126 appears to be largely positive among advocates for healthcare access and diabetes awareness. Supporters view the bill as a critical step toward ensuring that vulnerable populations obtain the medications that are vital for their health. However, there may be concerns regarding the adequacy of funding and resources to support these programs, especially given the number of eligible individuals identified.

Contention

Notable points of contention regarding SB126 include the administrative penalties levied on manufacturers for noncompliance with the program's stipulations. Manufacturers are subject to escalating fines if they fail to adhere to the standards set forth in the bill, which has sparked discussions about the balance of regulation and market predictability. Moreover, the eligibility restrictions for accessing the insulin programs, particularly concerning insurance coverage and income thresholds, may lead to debates on fairness and accessibility.

Companion Bills

No companion bills found.

Previously Filed As

KY HB729

AN ACT relating to pharmaceutical drug safety and declaring an emergency.

KY S01917

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

KY SB155

AN ACT relating to animal health emergencies and declaring an emergency.

KY HB612

AN ACT relating to regulated substances and declaring an emergency.

KY HB9

AN ACT relating to regulated substances and declaring an emergency.

KY SB202

AN ACT relating to regulated beverages and declaring an emergency.

KY HB757

AN ACT relating to revenue measures and declaring an emergency.

KY SB20

AN ACT relating to local entities and declaring an emergency.

KY HB896

AN ACT relating to hemp products and declaring an emergency.

KY HB370

AN ACT relating to transportation and declaring an emergency.

Similar Bills

CA SB277

Criminal procedure: search of persons.

CA AB1464

Housing preferences.

CA AB2161

Medi-Cal: redeterminations and work or community engagement.

CA AB2066

Triggering event: pregnancy.

CA SB257

PARENT Act.

IA HF2731

A bill for an act establishing the percentage of income payment plan program to be administered by the department of health and human services.

HI HB286

Relating To The Individual Housing Account Program.

HI HB286

Relating To The Individual Housing Account Program.